We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
13 hedge funds and large institutions have $795K invested in Cyclo Therapeutics, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 13 → 13 (0)
42% less capital invested
Capital invested by funds: $1.38M → $795K (-$581K)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Holders
13
Holders Change
–
Holders Change %
0%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.85K |
| 2 |
Wells Fargo
San Francisco,
California
|
+$10 |
Top Sellers
| 1 |
BlackRock
New York
|
-$43.2K |
| 2 |
Renaissance Technologies
New York
|
-$28.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.63K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$3.15K |
| 5 |
Morgan Stanley
New York
|
-$145 |